Request Demo
Last update 21 Jul 2025
IPG-8294
Last update 21 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms IPG 008, IPG-008, IPG008 + [1] |
Target |
Action inhibitors |
Mechanism CD38 inhibitors(Lymphocyte differentiation antigen CD38 inhibitors), Hydrolases inhibitors, NAD+ inhibitors(NAD(Nicotinamide adenine dinucleotide) inhibitors) |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Related
1
Clinical Trials associated with IPG-8294CTR20252251
一项评价IPG8294在健康成人受试者中的安全性、耐受性、药代动力学的随机、双盲、安慰剂对照、单剂量和多剂量递增的Ⅰ期临床首次人体试验
[Translation] A randomized, double-blind, placebo-controlled, single-dose and multiple-dose ascending phase I first-in-human trial to evaluate the safety, tolerability, and pharmacokinetics of IPG8294 in healthy adult subjects
100 Clinical Results associated with IPG-8294
Login to view more data
100 Translational Medicine associated with IPG-8294
Login to view more data
100 Patents (Medical) associated with IPG-8294
Login to view more data
100 Deals associated with IPG-8294
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Phase 1 | China | 01 Jul 2025 | |
| Mitochondrial Myopathies | Phase 1 | China | 01 Jul 2025 | |
| Amyotrophic Lateral Sclerosis | IND Application | China | 26 Aug 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free